Isolation and characterization of mesenchymal stem cells from human umbilical cord blood: Reevaluation of critical factors for successful isolation and high ability to proliferate and differentiate to chondrocytes as compared to mesenchymal stem cells from bone marrow and adipose tissue

Journal of Cellular Biochemistry

Volumn 112, Issue 4, 2011, Pages 1206-1218

  Zhang, Xiaohong ^a   Hirai, Masako ^a   Cantero, Susana ^a   Ciubotariu, Rodica ^a   Dobrila, Ludy ^a   Hirsh, Allen ^c   Igura, Koichi ^c   Satoh, Hitoshi ^d   Yokomi, Izuru ^e   Nishimura, Toshihide ^f   Yamaguchi, Satoru ^b   Yoshimura, Kotaro ^b   Rubinstein, Pablo ^a   Takahashi, Tsuneo A ^a  

^a NEW YORK BLOOD CENTER   (United States)

^b UNIVERSITY OF TOKYO   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Cellular proliferation; Chondrogenesis; Differentiation; Human umbilical cord blood; Mesenchymal stem cells

Indexed keywords

TELOMERASE;

ADIPOSE TISSUE; ARTICLE; BONE DEVELOPMENT; BONE MARROW; CARTILAGE CELL; CELL DIFFERENTIATION; CELL EXPANSION; CELL ISOLATION; CELL PROLIFERATION; CELL THERAPY; CHONDROGENESIS; CONTROLLED STUDY; CRYOPRESERVATION; ENZYME ACTIVITY; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; IN VIVO STUDY; MESENCHYMAL STEM CELL; NONHUMAN; OSTEOCLAST; PRIORITY JOURNAL; TELOMERE; UMBILICAL CORD BLOOD;

ADIPOSE TISSUE; ANTIGENS, CD146; BONE MARROW CELLS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SEPARATION; CELLS, CULTURED; CHONDROCYTES; CRYOPRESERVATION; FEMALE; FETAL BLOOD; FIBROBLASTS; GENE EXPRESSION; HUMANS; IMMUNOPHENOTYPING; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MEMBRANE PROTEINS; MESENCHYMAL STEM CELLS; OSTEOCLASTS; PLOIDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TELOMERASE; TELOMERE; TIME FACTORS;

EID: 79952557541     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23042     Document Type: Article

References (48)

1. Avanzini MA, Bernardo ME, Cometa AM, Perotti C, Zaffaroni N, Novara F, Visai L, Moretta A, Del Fante C, Villa R, Ball LM, Fibbe WE, Maccario R, Locatelli F. 2009. Generation of mesenchymal stromal cells in the presence of platelet lysate: A phenotypic and functional comparison of umbilical cord blood- and bone marrow-derived progenitors. Haematologica 94:1649-1660.
2. Ben-Naim E, Krapivsky PL. 1996. Nucleation and growth in one dimension. Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscipl Top 54:3562-3568. (Pubitemid 126584239)
3. Bieback K, Kern S, Kluter H, Eichler H. 2004. Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells 22:625-634. (Pubitemid 39014578)
4. Caplan AI. 2007. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 213:341-347. (Pubitemid 47509711)
5. Corselli M, Chen CW, Crisan M, Lazzari L, Peault B. 2010. Perivascular ancestors of adult multipotent stem cells. Arterioscler Thromb Vasc Biol 30:1104-1109.
6. Covas DT, Panepucci RA, Fontes AM, Silva WA, Jr., Orellana MD, Freitas MC, Neder L, Santos AR, Peres LC, Jamur MC, Zago MA. 2008. Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146+ perivascular cells and fibroblasts. Exp Hematol 36:642-654.
7. Dos Santos F, Andrade PZ, Boura JS, Abecasis MM, da Silva CL, Cabral JM. 2010. Ex vivo expansion of human mesenchymal stem cells: A more effective cell proliferation kinetics and metabolism under hypoxia. J Cell Physiol 223:27-35.
8. Erices A, Conget P, Minguell JJ. 2000. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol 109:235-242. (Pubitemid 30340601)
9. Fan X, Liu T, Liu Y, Ma X, Cui Z. 2009. Optimization of primary culture condition for mesenchymal stem cell derived from umbilical cord blood with factorial design. Biotechnol Prog 25:499-507.
10. Flynn A, Barry F, O'Brien T. 2007. UC blood-derived mesenchymal stromal cells: An overview. Cytotherapy 9:718-726.
11. Fong CY, Subramanian A, Biswas A, Gauthaman K, Srikanth P, Hande MP, Bongso A. 2010. Derivation efficiency, cell proliferation, freeze-thaw survival, stem-cell properties and differentiation of human Wharton's jelly stem cells. Reprod Biomed Online 21:391-401.
12. Garcia J. 2010. Allogeneic unrelated cord blood banking worldwide: An update. Transfus Apher Sci 42:257-263.
13. Harris DT. 2009. Non-haematological uses of cord blood stem cells. Br J Haematol 147:177-184.
14. Hirsh AG, Williams RJ, Mehl P. 1994. Kinetics of medfly mortality. Exp Gerontol 29:197-204. (Pubitemid 24118036)
15. Igura K, Zhang X, Takahashi K, Mitsuru S, Yamaguchi S, Takahashi TA. 2004. Isolation and characterization of mesenchymal progenitor cells from chorionic villi of human placenta. Cytotherapy 6:543-553. (Pubitemid 40028913)
16. Kern S, Eichler H, Stoeve J, Kluter H, Bieback K. 2006. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24:1294-1301. (Pubitemid 44464698)
17. Kluth SM, Buchheiser A, Houben AP, Geyh S, Krenz T, Radke TF, Wiek C, Hanenberg H, Reinecke P, Wernet P, Kögler G. 2010. DLK-1 as a marker to distinguish unrestricted somatic stem cells and mesenchymal stromal cells in cord blood. Stem Cells Dev 19:1471-1483.
18. Kögler G, Sensken S, Airey JA, Trapp T, Müschen M, Feldhahn N, Liedtke S, Sorg RV, Fischer J, Rosenbaum C, Greschat S, Knipper A, Bender J, Degistirici O, Gao J, Caplan AI, Colletti EJ, Almeida-Porada G, Müller HW, Zanjani E, Wernet P. 2004. A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med 200:123-135.
19. Kögler G, Radke TF, Lefort A, Sensken S, Fischer J, Sorg RV, Wernet P. 2005. Cytokine production and hematopoiesis supporting activity of cord blood-derived unrestricted somatic stem cells. Exp Hematol 33:573-583.
20. Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I, Lanino E, Sundberg B, Bernardo ME, Remberger M, Dini G, Egeler RM, Bacigalupo A, Fibbe W, Ringdén O, Developmental Committee of the European Group for Blood and Marrow Transplantation. 2008. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: A phase II study. Lancet 371:1579-1586.
21. Lee OK, Kuo TK, Chen WM, Lee KD, Hsieh SL, Chen TH. 2004. Isolation of multipotent mesenchymal stem cells from umbilical cord. Blood 103:1669-1675. (Pubitemid 38268958)
22. Maurice S, Srouji S, Livne E. 2007. Isolation of progenitor cells from cord blood using adhesion matrices. Cytotechnology 54:121-133.
23. Moerman EJ, Teng K, Lipschitz DA, Lecka-Czernik B. 2004. Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: The role of PPAR-gamma2 transcription factor and TGF-beta/ BMP signaling pathways. Aging Cell 3:379-389. (Pubitemid 40246708)
24. Morigi M, Rota C, Montemurro T, Montelatici E, Lo Cicero V, Imberti B, Abbate M, Zoja C, Cassis P, Longaretti L, Rebulla P, Introna M, Capelli C, Benigni A, Remuzzi G, Lazzari L. 2010. Life-sparing effect of human cord blood-mesenchymal stem cells in experimental acute kidney injury. Stem Cells 28:513-522.
25. Nauta AJ, Fibbe WE. 2007. Immunomodulatory properties of mesenchymal stromal cells. Blood 110:3499-3506. (Pubitemid 350159613)
26. Nishiyama N, Miyoshi S, Hida N, Uyama T, Okamoto K, Ikegami Y, Miyado K, Segawa K, Terai M, Sakamoto M, Ogawa S, Umezawa A. 2007. The significant cardiomyogenic potential of human umbilical cord blood-derived mesenchymal stem cells in vitro. Stem Cells 25:2017-2024. (Pubitemid 47258179)
27. Parolini O, Alviano F, Bagnara GP, Bilic G, Bühring HJ, Evangelista M, Hennerbichler S, Liu B, Magatti M, Mao N, Miki T, Marongiu F, Nakajima H, Nikaido T, Portmann-Lanz CB, Sankar V, Soncini M, Stadler G, Surbek D, Takahashi TA, Redl H, Sakuragawa N, Wolbank S, Zeisberger S, Zisch A, Strom SC. 2008. Concise review: Isolation and characterization of cells from human term placenta: Outcome of the first international workshop on placenta derived stem cells. Stem Cells 26:300-311. (Pubitemid 351413589)
28. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. 1999. Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147. (Pubitemid 29282067)
29. Prasad VK, Lucas KG, Kleiner GI, Talano JA, Jacobsohn D, Broadwater G, Monroy R, Kurtzberg J. 2010. Efficacy and safety of ex-vivo cultured adult human mesenchymal stem cells (Prochymal™) in pediatric patients with severe refractory acute graft-versus-host disease in a compassionate use study. Biol Blood Marrow Transplant DOI: 10.1016/j.bbmt.2010.04.014.
30. Prockop DJ. 2009. Repair of tissues by adult stem/progenitor cells (MSCs): Controversies, myths, and changing paradigms. Mol Ther 17:838-946.
31. Prockop DJ, Brenner M, Fibbe WE, Horwitz E, Le Blanc K, Phinney DG, Simmons PJ, Sensebe L, Keating A. 2010. Defining the risks of mesenchymal stromal cell therapy. Cytotherapy 12:576-578.
32. Reinisch A, Bartmann C, Rohde E, Schallmoser K, Bjelic-Radisic V, Lanzer G, Linkesch W, Strunk D. 2007. Humanized system to propagate cord blood-derived multipotent mesenchymal stromal cells for clinical application. Regen Med 2:371-382. (Pubitemid 47304957)
33. Rubinstein P. 2009. Cord blood banking for clinical transplantation. Bone Marrow Transplant 44:635-642.
34. Rubinstein P, Dobrila L, Rosenfield RE, Adamson JW, Migliaccio G, Migliaccio AR, Taylor PE, Stevens CE. 1995. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci USA 92:10119-10122.
35. Russell KC, Phinney DG, Lacey MR, Barrilleaux BL, Meyertholen KE, O'Connor KC. 2010. In vitro high-capacity assay to quantify the clonal heterogeneity in trilineage potential of mesenchymal stem cells reveals a complex hierarchy of lineage commitment. Stem Cells 28:788-798.
36. Salem HJ, Thiemermann C. 2010. Mesenchymal stromal cells: Current understanding and clinical status. Stem Cells 28:585-596.
37. Sarugaser R, Lickorish D, Baksh D, Hosseini MM, Davies JE. 2005. Human umbilical cord perivascular (HUCPV) cells: A source of mesenchymal progenitors. Stem Cells 23:220-229. (Pubitemid 40239517)
38. Secco M, Zucconi E, Vieira NM, Fogaça LL, Cerqueira A, Carvalho MD, Jazedje T, Okamoto OK, Muotri AR, Zatz M. 2008. Multipotent stem cells from umbilical cord: Cord is richer than blood! Stem Cells 26:146-150.
39. Sul HS. 2009. Minireview: Pref-1: Role in adipogenesis and mesenchymal cell fate. Mol Endocrinol 23:1717-1725.
40. Tarte K, Gaillard J, Lataillade JJ, Fouillard L, Becker M, Mossafa H, Tchirkov A, Rouard H, Henry C, Splingard M, Dulong J, Monnier D, Gourmelon P, Gorin NC, Sensebé L, Société Française de Greffe de Moelle et Thérapie Cellulaire. 2010. Clinical-grade production of human mesenchymal stromal cells: Occurrence of aneuploidy without transformation. Blood 115:1549-1553.
41. Troyer DL, Weiss ML. 2008. Wharton's jelly-derived cells are a primitive stromal cell population. Stem Cells 26:591-599.
42. Wagner JE, Gluckman E. 2010. Umbilical cord blood transplantation: The first 20 years. Semin Hematol 47:3-12.
43. Wang M, Yang Y, Yang D, Luo F, Liang W, Guo S, Xu J. 2009. The immunomodulatory activity of human umbilical cord blood-derived mesenchymal stem cells in vitro. Immunology 126:220-232.
44. Williams RJ, Takahashi T, Hirsh AG. 1992. The kinetics of autolysis in osmotically stressed sea urchin eggs. Thermochimica Acta 203:493-501.
45. Ye ZQ, Burkholder JK, Qiu P, Schultz JC, Shahidi NT, Yang NS. 1994. Establishment of an adherent cell feeder layer from human umbilical cord blood for support of long-term hematopoietic progenitor cell growth. Proc Natl Acad Sci USA 91:12140-12144. (Pubitemid 24368620)
46. Yu M, Xiao Z, Shen L, Li L. 2004. Mid-trimester fetal blood-derived adherent cells share characteristics similar to mesenchymal stem cells but full-term umbilical cord blood does not. Br J Haematol 124:666-675. (Pubitemid 38297101)
47. Zeddou M, Briquet A, Relic B, Josse C, Malaise MG, Gothot A, Lechanteur C, Beguin Y. 2010. The umbilical cord matrix is a better source of mesenchymal stem cells (MSC) than the umbilical cord blood. Cell Biol Int 34:693-701.
48. Zhang X, Mitsuru A, Igura K, Takahashi K, Ichinose S, Yamaguchi S, Takahashi TA. 2006. Mesenchymal progenitor cells derived from chorionic villi of human placenta for cartilage tissue engineering. Biochem Biophys Res Commun 340:944-952. (Pubitemid 43053919)